Literature DB >> 12136152

Crystallization and preliminary crystallographic analysis of the terminal oxygenase component of carbazole 1,9a-dioxygenase of Pseudomonas resinovorans strain CA10.

Jeong Won Nam1, Zui Fujimoto, Hiroshi Mizuno, Hisakazu Yamane, Takako Yoshida, Hiroshi Habe, Hideaki Nojiri, Toshio Omori.   

Abstract

The terminal oxygenase component (CarAa) of carbazole 1,9a-dioxygenase from Pseudomonas resinovorans strain CA10 was crystallized at 293 K using the sitting-drop vapour-diffusion method under the following conditions: 0.1 M sodium citrate pH 5.6 in the presence of 0.5 M ammonium sulfate and 1.0 M lithium sulfate. By using additive reagents with the crystallizing condition, improved diffraction was obtained from the crystals. Preliminary X-ray diffraction analysis indicated that CarAa crystals are hexagonal and belong to space group P6(2) or P6(4), with unit-cell parameters a = b = 244.5, c = 65.7 A, alpha = beta = 90.0, gamma = 120.0 degrees. Diffraction data were collected to 3.0 A resolution. The V(M) value is 2.16 A(3) Da(-1), which indicates a solvent content of 43.0%. This is the first report of crystallization of the terminal oxygenase component of an angular-type dioxygenase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136152     DOI: 10.1107/s0907444902009150

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  2 in total

1.  Purification and characterization of carbazole 1,9a-dioxygenase, a three-component dioxygenase system of Pseudomonas resinovorans strain CA10.

Authors:  Jeong-Won Nam; Hideaki Nojiri; Haruko Noguchi; Hiromasa Uchimura; Takako Yoshida; Hiroshi Habe; Hisakazu Yamane; Toshio Omori
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

2.  Two angular dioxygenases contribute to the metabolic versatility of dibenzofuran-degrading Rhodococcus sp. strain HA01.

Authors:  Hamdy A H Aly; Nguyen B Huu; Victor Wray; Howard Junca; Dietmar H Pieper
Journal:  Appl Environ Microbiol       Date:  2008-04-25       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.